These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38729070)

  • 1. Preclinical murine models for the testing of antimicrobials against Mycobacterium abscessus pulmonary infections: Current practices and recommendations.
    Dartois V; Bonfield TL; Boyce JP; Daley CL; Dick T; Gonzalez-Juarrero M; Gupta S; Kramnik I; Lamichhane G; Laughon BE; Lorè NI; Malcolm KC; Olivier KN; Tuggle KL; Jackson M
    Tuberculosis (Edinb); 2024 Jul; 147():102503. PubMed ID: 38729070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical murine models to study lung infection with Mycobacterium abscessus complex.
    Nicola F; Cirillo DM; Lorè NI
    Tuberculosis (Edinb); 2023 Jan; 138():102301. PubMed ID: 36603391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Host- and Pathogen-Directed Therapy for the Control of Mycobacterium abscessus Infection.
    Poerio N; Riva C; Olimpieri T; Rossi M; Lorè NI; De Santis F; Henrici De Angelis L; Ciciriello F; D'Andrea MM; Lucidi V; Cirillo DM; Fraziano M
    Microbiol Spectr; 2022 Feb; 10(1):e0254621. PubMed ID: 35080463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of
    Ignatius EH; Rimal B; Panthi CM; Belz DC; Lippincott CK; Deck DH; Serio AW; Lamichhane G
    mSphere; 2024 Jul; 9(7):e0038124. PubMed ID: 38980071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of pulmonary
    Flight WG; Hough NE; Chapman SJ
    Int J Mycobacteriol; 2020; 9(1):48-52. PubMed ID: 32474488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of Immunoglobulin Response to Nontuberculous Mycobacteria Infection in People with Cystic Fibrosis.
    Malcolm KC; Wheeler EA; Calhoun K; Lenhart-Pendergrass PM; Rysavy N; Poch KR; Caceres SM; Saavedra MT; Nick JA
    Microbiol Spectr; 2022 Aug; 10(4):e0187422. PubMed ID: 35863022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized cyclophosphamide-treated mouse model of
    Sun Y; Zhang K; Delos Santos M; Pee CJE; Yang Y; Kang M; Shin SJ; Chan-Park MB; Pethe K
    Antimicrob Agents Chemother; 2024 Aug; 68(8):e0152023. PubMed ID: 38990014
    [No Abstract]   [Full Text] [Related]  

  • 8. Activity of Oritavancin and Its Synergy with Other Antibiotics against
    Wang G; Tang J; Feng J; Dong W; Huo X; Lu H; Wang C; Lu W; Wang X; Chen H; Tan C
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198513
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Zhang T; Du J; Dong L; Wang F; Zhao L; Jia J; Wang C; Cheng M; Yu X; Huang H
    Microbiol Spectr; 2023 Feb; 11(1):e0323822. PubMed ID: 36475850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative and Experimental Therapies of
    Meir M; Barkan D
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948001
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimicrobial properties of basidiomycota macrofungi to
    Millar BC; Nelson D; Moore RE; Rao JR; Moore JE
    Int J Mycobacteriol; 2019; 8(1):93-97. PubMed ID: 30860186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro Efficacy of Free and Nanoparticle Formulations of Gallium(III) meso-Tetraphenylporphyrine against Mycobacterium avium and Mycobacterium abscessus and Gallium Biodistribution in Mice.
    Choi SR; Britigan BE; Switzer B; Hoke T; Moran D; Narayanasamy P
    Mol Pharm; 2018 Mar; 15(3):1215-1225. PubMed ID: 29421865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiostrepton: A Novel Therapeutic Drug Candidate for
    Kim TH; Hanh BTB; Kim G; Lee DG; Park JW; Lee SE; Kim JS; Kim BS; Ryoo S; Jo EK; Jang J
    Molecules; 2019 Dec; 24(24):. PubMed ID: 31835481
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.
    Kirkwood ZI; Millar BC; Downey DG; Moore JE
    Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.
    Johansen MD; Herrmann JL; Kremer L
    Nat Rev Microbiol; 2020 Jul; 18(7):392-407. PubMed ID: 32086501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sudapyridine (WX-081) antibacterial activity against
    Zheng L; Wang H; Qi X; Zhang W; Wang B; Fu L; Chen X; Chen X; Lu Y
    mSphere; 2024 Feb; 9(2):e0051823. PubMed ID: 38240581
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sur S; Patra T; Karmakar M; Banerjee A
    Crit Rev Microbiol; 2023 Aug; 49(4):499-514. PubMed ID: 35696783
    [No Abstract]   [Full Text] [Related]  

  • 18. Natural Products Lysobactin and Sorangicin A Show
    Sullivan JR; Yao J; Courtine C; Lupien A; Herrmann J; Müller R; Behr MA
    Microbiol Spectr; 2022 Dec; 10(6):e0267222. PubMed ID: 36342177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclohexyl-griselimycin Is Active against Mycobacterium abscessus in Mice.
    Aragaw WW; Roubert C; Fontaine E; Lagrange S; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0140021. PubMed ID: 34723632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifabutin Is Active against Mycobacterium abscessus in Mice.
    Dick T; Shin SJ; Koh WJ; Dartois V; Gengenbacher M
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.